BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4370454)

  • 1. The effect of 1-sarcosine, 8-leucyl angiotensin II on the pressor effect of infused angiotensin II.
    O'Connor GJ; Baranowski RL; Kurtzman NA
    Arch Int Pharmacodyn Ther; 1974 May; 209(1):75-9. PubMed ID: 4370454
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of angiotensin II antagonists in experimental hypertension.
    Bumpus FM; Smeby RR; Sweet C; Ferrario CM; Khosla MC
    Circ Res; 1973 May; 32():Suppl 1:150-8. PubMed ID: 4351356
    [No Abstract]   [Full Text] [Related]  

  • 3. Renin release and ketamine-induced cardiovascular stimulation in the rat.
    Tanaka K; Pettinger WA
    J Pharmacol Exp Ther; 1974 Jan; 188(1):229-33. PubMed ID: 4358437
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inhibiting effect of (sarcosine-1-isoleucine-8)-angiotensin II in anesthesized rats].
    Gandarias JM; Casis L; Casis E; Gómez R; Iribar C
    Rev Esp Fisiol; 1987 Mar; 43(1):77-80. PubMed ID: 3616115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological doses of [Ile5]- and [Val5]-Angiotensin II fail to increase plasma catecholamines at the peak pressor response in rats.
    Butler DG; Butt DA
    Arch Int Pharmacodyn Ther; 1995; 329(2):272-82. PubMed ID: 8540766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new class of angiotensin II analogs: substitution of sarcosine in position 7.
    Moore G; Oudeman E; Gorman P
    Proc West Pharmacol Soc; 1978; 21():261-6. PubMed ID: 693506
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro and in vivo studies of (1-sarcosine, 8-threonine) angiotensin II.
    Muñoz-Ramírez H; Khosla MC; Hall MM; Bumpus FM; Khairallah PA
    Res Commun Chem Pathol Pharmacol; 1976 Apr; 13(4):649-63. PubMed ID: 4864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of microsomal leucine aminopeptidase from human placenta (microsomal P-LAP) on pressor response to infused angiotensin II (A-II) in rat.
    Mizutani S; Taira H; Kurauchi O; Ito Y; Imaizumi H; Furuhashi M; Narita O; Tomoda Y
    Exp Clin Endocrinol; 1987 Sep; 90(2):206-12. PubMed ID: 3428362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a nitric oxide synthase inhibitor on pressor response to angiotensin II in conscious rats.
    Maeda T; Yoshimura T; Ohshige A; Koyama H; Ito M; Okamura H
    Artery; 1998; 23(1):1-9. PubMed ID: 10846613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rise in plasma angiotensin II and of blood pressure induced by 5-hydroxytryptamine in rats.
    Ylitalo P
    Ann Med Exp Biol Fenn; 1972; 50(4):191-4. PubMed ID: 4352050
    [No Abstract]   [Full Text] [Related]  

  • 11. Cause of the prolonged pressor action of renin in nephrectomized rats. Elucidated by means of anti-angiotensin II and of angiotensin-inhibitor (1-sar-8-ala-angiotensin II).
    Bing J; Nielsen K
    Acta Pathol Microbiol Scand A; 1973 May; 81(3):247-53. PubMed ID: 4358385
    [No Abstract]   [Full Text] [Related]  

  • 12. Analogues of angiotensin II with restricted conformational freedom, including a new antagonist.
    Turk J; Needleman P; Marshall GR
    Mol Pharmacol; 1976 Mar; 12(2):217-24. PubMed ID: 1264066
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis of angiotensin II antagonists containing sarcosine in position 7.
    Moore GJ; Oudeman EM; Ko D; Nystrom DM
    J Med Chem; 1979 Sep; 22(9):1147-9. PubMed ID: 490564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of peripheral and central effects of angiotensin II by (1-sarcosine, 8-isoleucine)angiotensin II.
    Sweet CS; Ferrario CM; Khosla MC; Bumpus FM
    J Pharmacol Exp Ther; 1973 Apr; 185(1):35-41. PubMed ID: 4348281
    [No Abstract]   [Full Text] [Related]  

  • 15. Central injection of galanin inhibits angiotensin II-induced responses in rats.
    Hirase M; Ono K; Yamashita H; Inenaga K
    Neuroreport; 2008 Feb; 19(3):323-6. PubMed ID: 18303575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin analogs: the influence of sarcosine substituted in position 1.
    Hall MM; Khosla MC; Khairallah PA; Bumpus FM
    J Pharmacol Exp Ther; 1974 Jan; 188(1):222-8. PubMed ID: 4358436
    [No Abstract]   [Full Text] [Related]  

  • 17. A new, long-lasting competitive inhibitor of angiotensin.
    Türker RK; Hall MM; Yamamoto M; Sweet CS; Bumpus FM
    Science; 1972 Sep; 177(4055):1203-5. PubMed ID: 4341570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Central A II-antagonism in experimental hypertension].
    Schölkens BA
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():240. PubMed ID: 565989
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitory effects of central hypertensive activity of angiotensin I and II by 1-sar-8-ala-angiotensin II (saralasin acetate).
    Solomon TA; Buckley JP
    J Pharm Sci; 1974 Jul; 63(7):1109-13. PubMed ID: 4368826
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin II analogues. 12. Role of the aromatic ring of position 8 phenylalanine in pressor activity.
    Hsieh K; Jorgensen EC; Lee TC
    J Med Chem; 1979 Sep; 22(9):1038-44. PubMed ID: 490548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.